ROKIT Healthcare Inc. (KOSDAQ:376900)

South Korea flag South Korea · Delayed Price · Currency is KRW
50,600
-4,000 (-7.33%)
Last updated: Nov 18, 2025, 1:13 PM KST
-7.33%
Market Cap792.32B
Revenue (ttm)15.91B
Net Income (ttm)-7.90B
Shares Out15.41M
EPS (ttm)-871.15
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,963,257
Average Volume1,426,712
Open56,700
Previous Close54,600
Day's Range49,950 - 57,200
52-Week Range13,740 - 54,600
Betan/a
RSI70.20
Earnings DateNov 14, 2025

About ROKIT Healthcare

ROKIT Healthcare Inc., a biotechnology company, provides hyper-personalized organ regenerative healthcare solutions in South Korea. The company offers skin regeneration therapy for the treatment of diabetic foot ulcers; cartilage regeneration delivers hyper-personalized therapeutic solutions for osteoarthritis patients; and kidney regeneration, a hyper-personalized treatment for chronic kidney disease (CKD). It also provides bioprinters; bioinks; Huma Media, a human adult stem cell culture media; HumaTein, a human cell-derived whole extracellul... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2012
Employees 74
Stock Exchange KOSDAQ
Ticker Symbol 376900
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.